| Notice of NIBIB Participation to PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)" |
NOT-EB-21-016 |
|
|
| Notice of NIBIB Specific Interests and Guidance in RFA-NS-23-006 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) |
NOT-EB-22-012 |
|
|
| Notice of NIBIB Specific Interests and Guidance in RFA-NS-23-007 "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
NOT-EB-22-013 |
|
|
| Notice of NIBIB Withdrawal from PAR-20-155, "Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)" |
NOT-EB-21-031 |
|
|
| Notice of NIBIB Withdrawal from PAR-21-166, "Academic-Industrial Partnerships of Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)" |
NOT-EB-21-032 |
|
|
| Notice of NIBIB's Participation in RFA-HG-16-016 "BD2K RFA-HG-Open Educational Resources for Skills Development in Biomedical Big Data Science (R25) |
NOT-EB-16-007 |
|
|
| Notice of NIBIB's Participation in NOT-MD-19-022 "Notice of Correction in Expiration Date for PAR-18-331 "Simulation Modeling and Systems Science to Address Health Disparities (R01 Clinical Trial Not Allowed)" |
NOT-EB-19-012 |
|
|
| Notice of NIBIB's Participation in NOT-TR-18-027 "Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose" |
NOT-EB-18-023 |
|
|
| Notice of NIBIB's Participation in PA-14-307 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)" |
NOT-EB-14-006 |
|
|
| Notice of NIBIB's Participation in PA-14-308 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)" |
NOT-EB-14-005 |
|
|
